Results 231 to 240 of about 2,128,557 (346)
FIBRILACIÓN AURICULAR EN EL PACIENTE HIPERTENSO. PAPEL DE LA AURÍCULA IZQUIERDA / Atrial fibrillation in hypertensive patients. Role of the left atrium [PDF]
Elibet Chávez González
doaj
Barriers to incorporating pharmacogenetics into routine clinical practice in the United States are well documented. Initial surveys by the Clinical Pharmacogenetics Implementation Consortium (CPIC) in 2009 and 2010 identified barriers across four key domains that have hindered the widespread adoption of clinical pharmacogenetic testing.
D. Max Smith+18 more
wiley +1 more source
Letter by He Regarding Article, “Adenosine-Induced Atrial Fibrillation: Localized Reentrant Drivers in Lateral Right Atria Due to Heterogeneous Expression of Adenosine A1 Receptors and GIRK4 Subunits in the Human Heart” [PDF]
Yong‐Ming He
openalex +1 more source
CYP2C19 loss‐of‐function (LOF) alleles decrease the antiplatelet effect of clopidogrel following percutaneous coronary intervention (PCI) in patients presenting with acute coronary syndrome (ACS). The impact of genotype in patients undergoing PCI for stable ischemic heart disease (SIHD) in real‐world populations is less clear.
Catherine Chanfreau‐Coffinier+20 more
wiley +1 more source
Syncope as the First Clue to a Congenital Heart Defect. [PDF]
Soni R, Morris V, Karfunkle B.
europepmc +1 more source
This study compared the number and cumulative dose of antibiotic dispensings among new users of sodium–glucose cotransporter‐2 (SGLT2) inhibitors and dipeptidyl peptidase‐4 (DPP4) inhibitors following hospital discharge in individuals with type 2 diabetes.
Maria J. Alfonso Arvez+5 more
wiley +1 more source
Giant Coronary Artery Aneurysms and Cardiac Pseudo Tumours from IgG4 Related Disease: A Case Report. [PDF]
Soh RY, Yeo TC, Cherian R.
europepmc +1 more source
Effects of KATP channel openers diazoxide and pinacidil in coronary-perfused atria and ventricles from failing and non-failing human hearts [PDF]
Vadim V. Fedorov+9 more
openalex +1 more source